Introduction
Efficacy and safety of Herceptin® in women with metastatic breast cancer: results from pivotal clinical studies
Maximizing the response to Herceptin® therapy through optimal use and patient selection
Trials of new combinations of Herceptin® in metastatic breast cancer
Herceptin®: the future in adjuvant breast cancer therapy